Turkish Cargo has recently upgraded its cold chain logistics capabilities, aiming to better serve the pharmaceutical and healthcare sectors. With the increasing global demand for temperature-sensitive products, particularly vaccines, biologics, and other medical supplies, Turkish Cargo has introduced state-of-the-art refrigerated containers and enhanced monitoring systems to ensure product integrity throughout the journey.
The carrier’s cold chain service, known as “TK Pharma,” has expanded to include specialized containers capable of maintaining precise temperature controls for ultra-sensitive shipments, ranging from -80°C to +25°C. This advancement is critical for the transportation of COVID-19 vaccines, as well as other pharmaceuticals that require strict compliance with international health and safety standards.
Global Reach and Precision Delivery
Turkish Cargo has developed a comprehensive network of certified pharma stations across major global hubs. These hubs are fully equipped with advanced cooling infrastructure, ensuring that pharmaceuticals are stored and handled in the most optimal conditions. The carrier has also enhanced real-time tracking and monitoring of these shipments, giving clients complete transparency and peace of mind.
The company’s investment in specialized pharma logistics is part of a broader strategy to become a key player in the air cargo industry’s healthcare sector. With growing demand for the rapid and safe transportation of medical supplies, Turkish Cargo’s cold chain services are positioning it as a trusted partner for pharmaceutical companies across the globe.
By expanding its cold chain capabilities, Turkish Cargo is responding to the needs of the healthcare industry, offering faster and safer delivery of critical medical supplies to destinations worldwide.
